EP0030795A3
(en)
*
|
1979-12-06 |
1981-09-09 |
Imperial Chemical Industries Plc |
Quinoxaline derivatives, processes therefor, pharmaceutical compositions, and benzene derivatives
|
DE3032994A1
(de)
*
|
1980-09-02 |
1982-04-22 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue pyrazino-azepine, deren herstellung und diese sie enthaltende arzneimittel
|
JPS62198671A
(ja)
*
|
1986-02-25 |
1987-09-02 |
Toyo Jozo Co Ltd |
1−置換アルキル1,2−ジヒドロ−2−ピラジノン誘導体
|
JPS62281878A
(ja)
*
|
1986-02-26 |
1987-12-07 |
Taisho Pharmaceut Co Ltd |
アザアントラセン化合物
|
JPH0678319B2
(ja)
*
|
1986-03-11 |
1994-10-05 |
東ソー株式会社 |
キノキサリノン誘導体
|
JPS6450868A
(en)
*
|
1987-08-21 |
1989-02-27 |
Toyo Jozo Kk |
1-substituted alkyl-2-oxo-1,2-dihydroquinoxaline derivative
|
JPH0276860A
(ja)
*
|
1987-10-05 |
1990-03-16 |
Toyo Jozo Co Ltd |
6−置換アルコキシ−2−オキソ−1,2−ジヒドロキノキサリン誘導体
|
NO179551C
(no)
*
|
1987-11-10 |
1996-10-30 |
Novo Nordisk As |
Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
|
GB9413975D0
(en)
*
|
1994-07-11 |
1994-08-31 |
Fujisawa Pharmaceutical Co |
New heterobicyclic derivatives
|
AU9049391A
(en)
*
|
1990-12-20 |
1992-07-22 |
Warner-Lambert Company |
2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
|
DE4217952A1
(de)
*
|
1992-05-30 |
1993-12-02 |
Basf Ag |
Chinoxalin-2,3(1H,4H)-dione
|
FR2696456B1
(fr)
*
|
1992-10-07 |
1995-01-06 |
Pf Medicament |
Dérivés de dihydro-1,2 oxo amino-3 quinoxalines, leur préparation et leur application en thérapeutique.
|
DE4340045A1
(de)
*
|
1993-11-24 |
1995-06-01 |
Basf Ag |
Neue Chinoxaline und Arzneimittel daraus
|
AU1599395A
(en)
*
|
1994-01-03 |
1995-08-01 |
Cocensys, Inc. |
8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
|
GB2291422A
(en)
*
|
1994-07-18 |
1996-01-24 |
Fujisawa Pharmaceutical Co |
4-phenyl-pyrido[2,3-b]pyrazin-4-ones
|
FR2731221B1
(fr)
*
|
1995-03-01 |
1997-05-30 |
Pf Medicament |
Nouveaux derives de l'ethyl-1 dihydro-1, 2 oxo-2 methylamino-3 quinoxaline, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
|
GB9526558D0
(en)
*
|
1995-12-27 |
1996-02-28 |
Fujisawa Pharmaceutical Co |
Heterobicyclic derivatives
|
ZA973884B
(en)
*
|
1996-05-23 |
1998-11-06 |
Du Pont Merck Pharma |
Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
|
EP1380298A3
(en)
*
|
1996-05-23 |
2004-04-07 |
Bristol-Myers Squibb Pharma Company |
Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders, anorexia, inflammation
|
US5869487A
(en)
*
|
1996-10-24 |
1999-02-09 |
Merck & Co., Inc. |
Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
|
US6087373A
(en)
*
|
1997-09-23 |
2000-07-11 |
Merck & Co., Inc. |
Thrombin inhibitors
|
IL142147A0
(en)
*
|
1998-09-29 |
2002-03-10 |
Fujisawa Pharmaceutical Co |
Methanesulfonate pyridopyrazine derivatives and pharmaceutical compositions containing the same
|
US6239132B1
(en)
|
1999-04-23 |
2001-05-29 |
Merck & Co., Inc. |
Thrombin inhibitors
|
JP2003501389A
(ja)
|
1999-06-04 |
2003-01-14 |
メルク エンド カムパニー インコーポレーテッド |
トロンビン阻害物質
|
EP1392309B1
(en)
*
|
2001-05-14 |
2007-01-17 |
Bristol-Myers Squibb Company |
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
|
SE0302323D0
(sv)
*
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
SE0302324D0
(sv)
*
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
SE0302486D0
(sv)
|
2003-09-18 |
2003-09-18 |
Astrazeneca Ab |
Novel compounds
|
CA2540638A1
(en)
*
|
2003-09-30 |
2005-04-14 |
Janssen Pharmaceutica N.V. |
Quinoxaline compounds
|
MXPA06005019A
(es)
*
|
2003-11-03 |
2006-07-06 |
Warner Lambert Co |
Nuevos inhibidores de la recaptacion de norpinefrina para el tratamiento de transtornos del sistema nervioso central.
|
CN1901917A
(zh)
*
|
2004-01-06 |
2007-01-24 |
詹森药业有限公司 |
作为糖原磷酸化酶抑制剂用于治疗糖尿病和肥胖症的(3-氧代-3,4-二氢-喹喔啉-2-基-氨基)-苯甲酰胺衍生物和相关化合物
|
MX2007001615A
(es)
*
|
2004-08-09 |
2007-04-10 |
Warner Lambert Co |
Nuevos inhibidores de la recaptacion de norepinefrina de quinoxalinona para el tratamiento de trastornos del sistema nervioso central.
|
US7601716B2
(en)
*
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
TW200808771A
(en)
|
2006-05-08 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds II
|
TW200808763A
(en)
|
2006-05-08 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds I
|
DE102007050673A1
(de)
|
2007-10-19 |
2009-04-23 |
Friedrich-Schiller-Universität Jena |
Neue Hexaaza-acene und Verfahren zu ihrer Herstellung
|
JP2011502982A
(ja)
|
2007-11-06 |
2011-01-27 |
アストラゼネカ・アクチエボラーグ |
好中球エラスターゼの阻害剤としてのある種の2−ピラジノン誘導体およびその使用
|
JP5530370B2
(ja)
*
|
2008-03-05 |
2014-06-25 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
インスリン分泌刺激剤としてのピラジノン誘導体、それらを得る方法および糖尿病を治療するためのそれらの使用
|
PT2247292T
(pt)
|
2008-03-05 |
2017-07-17 |
Merck Patent Gmbh |
Derivados de piridopirazinonas como estimulantes da secreção de insulina, procedimentos para a sua obtenção e a sua utilização no tratamento da diabetes
|
TW201036957A
(en)
|
2009-02-20 |
2010-10-16 |
Astrazeneca Ab |
Novel salt 628
|
TWI460159B
(zh)
|
2009-06-26 |
2014-11-11 |
Ihara Chemical Ind Co |
酮基丙二酸化合物或其水合物之製造方法
|
WO2011039528A1
(en)
|
2009-10-02 |
2011-04-07 |
Astrazeneca Ab |
2-pyridone compounds used as inhibitors of neutrophil elastase
|
JP5921500B2
(ja)
|
2013-07-19 |
2016-05-24 |
イハラケミカル工業株式会社 |
ケトマロン酸化合物の製造方法
|
KR102134407B1
(ko)
|
2014-02-17 |
2020-07-15 |
구미아이 가가쿠 고교 가부시키가이샤 |
유통 반응기를 사용한 케토말론산 화합물의 연속 제조방법
|
PL3394046T3
(pl)
*
|
2015-12-24 |
2022-06-13 |
The Regents Of The University Of California |
Regulatory cftr i sposoby ich zastosowania
|
EP3672598A4
(en)
|
2017-08-24 |
2021-04-28 |
The Regents of The University of California |
OCULAR PHARMACEUTICAL COMPOSITIONS
|